Kestra Medical Technologies director sells $97,504 in shares

Kestra Medical Technologies, a company listed on the NASDAQ under the ticker symbol KMTS, experienced a director selling a portion of their shares on September 30, 2026. Raymond W. Cohen, one of the company's directors, sold 3,330 shares worth $97,504. The transaction was executed at a price range of $29.2800 to $29.2900 per share, occurring near the company's 52-week high of $30.

This sale was made to meet tax withholding obligations related to the vesting and settlement of restricted stock units. Cohen currently owns 54,790 common shares in Kestra Medical Technologies.

In other news, the company released its first-quarter 2027 results, which showed a revenue of $31 million, a 60% increase from the previous year, and exceeded the consensus estimate of $29 million. However, Kestra Medical reported a wider-than-expected loss of $0.75 per share, compared to analysts' forecasts of a $0.45 loss per share. Despite this, the company raised its full-year revenue guidance from $137 million to $141 million.

Both Piper Sandler and Stifel maintained positive outlooks for Kestra Medical. Piper Sandler kept an Overweight rating with a $30.00 price target, praising the company's solid gross margin performance and the raised sales guidance for fiscal 2027. Stifel also retained a Buy rating with the same price target, highlighting the company's strong growth and revised full-year sales guidance. These developments suggest a promising future for Kestra Medical, despite the unexpected earnings loss.